BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18486922)

  • 1. DNase 1 and systemic lupus erythematosus.
    Martínez Valle F; Balada E; Ordi-Ros J; Vilardell-Tarres M
    Autoimmun Rev; 2008 May; 7(5):359-63. PubMed ID: 18486922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of systemic lupus erythematosus in Dnase1-deficient mice.
    Napirei M; Karsunky H; Zevnik B; Stephan H; Mannherz HG; Möröy T
    Nat Genet; 2000 Jun; 25(2):177-81. PubMed ID: 10835632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex immunogenetic basis of systemic lupus erythematosus.
    Castro J; Balada E; Ordi-Ros J; Vilardell-Tarrés M
    Autoimmun Rev; 2008 May; 7(5):345-51. PubMed ID: 18486920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of genetic variations in signalling/immunoregulatory molecules in susceptibility to systemic lupus erythematosus.
    Akahoshi M; Nakashima H; Shirakawa T
    Semin Immunol; 2006 Aug; 18(4):224-9. PubMed ID: 16678436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNaseI in pathogenesis of systemic lupus erythematosus.
    Tsukumo S; Yasutomo K
    Clin Immunol; 2004 Oct; 113(1):14-8. PubMed ID: 15380524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of DNASE1 in people with systemic lupus erythematosus.
    Yasutomo K; Horiuchi T; Kagami S; Tsukamoto H; Hashimura C; Urushihara M; Kuroda Y
    Nat Genet; 2001 Aug; 28(4):313-4. PubMed ID: 11479590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus, DNase and defective disposal of cellular debris.
    Walport MJ
    Nat Genet; 2000 Jun; 25(2):135-6. PubMed ID: 10835621
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular analysis of HumDN1 VNTR polymorphism of the human deoxyribonuclease I in systemic lupus erythematosus.
    AlFadhli S; AlTamimy B; Kharrat N; AlSaeid K; Haider MZ; Rebai A
    Int J Immunogenet; 2010 Feb; 37(1):5-8. PubMed ID: 19863681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNase 1 activity in patients with systemic lupus erythematosus: relationship with epidemiological, clinical, immunological and therapeutical features.
    Martinez-Valle F; Balada E; Ordi-Ros J; Bujan-Rivas S; Sellas-Fernandez A; Vilardell-Tarres M
    Lupus; 2009 Apr; 18(5):418-23. PubMed ID: 19318394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus-erythematosus: deoxyribonuclease 1 in necrotic chromatin disposal.
    Napirei M; Gültekin A; Kloeckl T; Möröy T; Frostegård J; Mannherz HG
    Int J Biochem Cell Biol; 2006 Mar; 38(3):297-306. PubMed ID: 16352456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of human systemic lupus erythematosus: the emerging picture.
    Nath SK; Kilpatrick J; Harley JB
    Curr Opin Immunol; 2004 Dec; 16(6):794-800. PubMed ID: 15511675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General aspects of the genetics of SLE.
    Rhodes B; Vyse TJ
    Autoimmunity; 2007 Dec; 40(8):550-9. PubMed ID: 18075789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E; Puccetti A; Gerli R; Rigo A; Migliorini P; Simeoni S; Beri R; Dolcino M; Martinelli N; Corrocher R; Lunardi C
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the genetic basis and immunopathogenesis of systemic lupus erythematosus from the study of mouse models.
    Cheung YH; Loh C; Pau E; Kim J; Wither J
    Semin Immunol; 2009 Dec; 21(6):372-82. PubMed ID: 19926489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of apoptosis in autoimmunity: immunogen, antigen, and accelerant.
    Levine JS; Koh JS
    Semin Nephrol; 1999 Jan; 19(1):34-47. PubMed ID: 9952279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow.
    Prokunina L; Alarcon-Riquelme M
    Hum Mol Genet; 2004 Apr; 13 Spec No 1():R143-8. PubMed ID: 14764622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis.
    AlFadhli S; Ghanem AA
    Immunol Invest; 2014; 43(5):411-23. PubMed ID: 24564745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in the pathogenesis of systemic lupus erythematosus.
    Munoz LE; van Bavel C; Franz S; Berden J; Herrmann M; van der Vlag J
    Lupus; 2008 May; 17(5):371-5. PubMed ID: 18490410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic lupus erythematosus--a contemporary view of its genetic determination, immunopathogenesis and therapy].
    Buc M; Rovenský J
    Epidemiol Mikrobiol Imunol; 2009 Feb; 58(1):3-14. PubMed ID: 19358447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyribonuclease 1-Mediated Clearance of Circulating Chromatin Prevents From Immune Cell Activation and Pro-inflammatory Cytokine Production, a Phenomenon Amplified by Low Trap1 Activity: Consequences for Systemic Lupus Erythematosus.
    Felux J; Erbacher A; Breckler M; Hervé R; Lemeiter D; Mannherz HG; Napirei M; Rammensee HG; Decker P
    Front Immunol; 2021; 12():613597. PubMed ID: 33746957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.